HighTower Advisors LLC Has $9.12 Million Position in HealthEquity, Inc. (NASDAQ:HQY)

HighTower Advisors LLC raised its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 4.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 95,075 shares of the company's stock after purchasing an additional 4,370 shares during the period. HighTower Advisors LLC owned approximately 0.11% of HealthEquity worth $9,122,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of the company. Wealthfront Advisers LLC acquired a new position in shares of HealthEquity in the fourth quarter valued at approximately $10,304,089,000. Wasatch Advisors LP boosted its holdings in shares of HealthEquity by 6.6% in the third quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company's stock valued at $635,065,000 after buying an additional 483,269 shares during the period. State Street Corp boosted its holdings in shares of HealthEquity by 0.8% in the third quarter. State Street Corp now owns 3,131,900 shares of the company's stock valued at $256,346,000 after buying an additional 23,613 shares during the period. Geode Capital Management LLC boosted its holdings in shares of HealthEquity by 0.7% in the third quarter. Geode Capital Management LLC now owns 2,078,977 shares of the company's stock valued at $170,197,000 after buying an additional 15,145 shares during the period. Finally, Franklin Resources Inc. boosted its holdings in shares of HealthEquity by 0.7% in the third quarter. Franklin Resources Inc. now owns 1,640,215 shares of the company's stock valued at $139,369,000 after buying an additional 11,659 shares during the period. Institutional investors own 99.55% of the company's stock.

Remove Ads

HealthEquity Stock Performance

NASDAQ:HQY traded up $0.28 during mid-day trading on Friday, reaching $84.88. 1,740,578 shares of the company's stock were exchanged, compared to its average volume of 693,963. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $115.59. The firm has a market capitalization of $7.36 billion, a PE ratio of 77.87, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. The business's fifty day simple moving average is $105.20 and its two-hundred day simple moving average is $95.51. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20.

Insider Buying and Selling

In related news, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the transaction, the director now directly owns 78,219 shares of the company's stock, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 2.20% of the stock is owned by insiders.

Analyst Ratings Changes

Several research analysts recently commented on the stock. Wells Fargo & Company increased their target price on shares of HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a report on Wednesday, February 26th. Royal Bank of Canada increased their target price on shares of HealthEquity from $100.00 to $105.00 and gave the stock an "outperform" rating in a report on Tuesday, December 10th. Raymond James increased their target price on shares of HealthEquity from $105.00 to $120.00 and gave the stock an "outperform" rating in a report on Tuesday, February 25th. Mizuho started coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They issued an "outperform" rating and a $126.00 price target for the company. Finally, JMP Securities increased their price target on shares of HealthEquity from $105.00 to $107.00 and gave the company a "market outperform" rating in a research note on Tuesday, December 10th. One equities research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $112.92.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.